March 9, 2020 / 7:17 AM / in 24 days

BRIEF-Cadila Healthcare Says FDA Inspected Formulations Manufacturing Facility From March 2 to March 9

March 9 (Reuters) - Cadila Healthcare Ltd:

* U.S. FDA INSPECTED CO’S FORMULATIONS MANUFACTURING FACILITY

* INSPECTION FROM 2ND TO 9TH MARCH

* AT END OF INSPECTION, NO OBSERVATION (483) ISSUED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below